title: New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases .
abstract: With the increase in new therapies to treat cancer, improved diagnostic tools are needed to help determine best treatment options. Many radiopharmaceuticals used with positron-emission tomography/computed tomography have been tested to evaluate solid cancers. Two of the newer radiopharmaceuticals are 18F sodium fluoride and radiolabeled choline. This article reviews these new technologies, providing background and potential clinical use.
authors.affiliation: School of Nursing, Columbia University, New York, NY.
authors.forename: Susan
authors.initials: S
authors.lastname: Doyle-Lindrud
mesh_terms: D001859:Bone Neoplasms / Q000175:diagnosis* / Q000556:secondary*; D002794:Choline; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications / Q000473:pathology; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods*; D011856:Radiographic Image Enhancement / Q000379:methods; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D002794:Choline
keywords: computed tomography; diagnostic tools; positron-emission tomography; radiopharmaceuticals